Your browser doesn't support javascript.
loading
Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo.
Takeda, Hiroyuki; Okada, Masashi; Kuramoto, Kenta; Suzuki, Shuhei; Sakaki, Hirotsugu; Sanomachi, Tomomi; Seino, Shizuka; Yoshioka, Takashi; Hirano, Hirofumi; Arita, Kazunori; Kitanaka, Chifumi.
Affiliation
  • Takeda H; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Okada M; Department of Clinical Oncology, Yamagata University School of Medicine, Yamagata, Japan.
  • Kuramoto K; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Suzuki S; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Sakaki H; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Sanomachi T; Department of Clinical Oncology, Yamagata University School of Medicine, Yamagata, Japan.
  • Seino S; Department of Obstetrics and Gynecology, Yamagata University School of Medicine, Yamagata, Japan.
  • Yoshioka T; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Hirano H; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Arita K; Research Institute for Promotion of Medical Sciences, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Kitanaka C; Department of Clinical Oncology, Yamagata University School of Medicine, Yamagata, Japan.
Oncotarget ; 8(53): 90996-91008, 2017 Oct 31.
Article in En | MEDLINE | ID: mdl-29207619

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: Japan